These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37974964)

  • 21. A First-in-Human Trial of GLS4, a Novel Inhibitor of Hepatitis B Virus Capsid Assembly, following Single- and Multiple-Ascending-Oral-Dose Studies with or without Ritonavir in Healthy Adult Volunteers.
    Zhao N; Jia B; Zhao H; Xu J; Sheng X; Luo L; Huang Z; Wang X; Ren Q; Zhang Y; Zhao X; Cui Y
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology of the hepatitis B virus (HBV) core and capsid assembly modulators (CAMs) for chronic hepatitis B (CHB) cure.
    McFadden WM; Sarafianos SG
    Glob Health Med; 2023 Aug; 5(4):199-207. PubMed ID: 37655181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein.
    Wang J; Zhang H; Zhang Y; Jiang D; Li J; Goldmann S; Ren Q; Fei R; Wang X; Wei L
    J Med Virol; 2017 Oct; 89(10):1804-1810. PubMed ID: 28401569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors.
    Liu L; Wang M; Li C; Han X; Xie Y; Feng K; Zhang L; Chen Y; Jia H
    Bioorg Chem; 2022 Nov; 128():106052. PubMed ID: 35921789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays.
    Wang Y; Wang Z; Liu J; Wang Y; Wu R; Sheng R; Hou T
    Bioorg Med Chem; 2021 Apr; 36():116096. PubMed ID: 33721800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacophore-Based Virtual Screening and Structural Modification of Novel Benzamide Derivatives as HBV Capsid Assembly Modulators.
    Qin Y; Wang S; Wang Y; Wang Y; Tao X; Zhao H; Wang H; Yu S; Sheng R
    Biol Pharm Bull; 2023; 46(9):1277-1288. PubMed ID: 37661407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection.
    Burdette D; Hyrina A; Song Z; Beran RK; Cheung T; Gilmore S; Kobayashi T; Li L; Liu Y; Niedziela-Majka A; Medley J; Mehra U; Morganelli P; Novikov N; Niu C; Tam D; Tang J; Wang J; Yue Q; Fletcher SP; Holdorf MM; Delaney WE; Feierbach B; Lazerwith S
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0134822. PubMed ID: 36519892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.
    Wu G; Liu B; Zhang Y; Li J; Arzumanyan A; Clayton MM; Schinazi RF; Wang Z; Goldmann S; Ren Q; Zhang F; Feitelson MA
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5344-54. PubMed ID: 23959305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An automated microfluidic platform for the screening and characterization of novel hepatitis B virus capsid assembly modulators.
    Vermes T; Kielpinski M; Henkel T; Pericàs MA; Alza E; Corcuera A; Buschmann H; Goldner T; Urban A
    Anal Methods; 2022 Jan; 14(2):135-146. PubMed ID: 34918017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.
    Zhao Q; Hu Z; Cheng J; Wu S; Luo Y; Chang J; Hu J; Guo JT
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of 5-alkyl-2-pyrazol-oxazolidin-4-one derivatives as novel hepatitis B virus capsid assembly modulators.
    Guan M; Wang Y; Wang Y; Chen N; Shi S; Sheng R
    Arch Pharm (Weinheim); 2023 Jun; 356(6):e2200592. PubMed ID: 37021586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical characterization of a novel potent core protein assembly modulator for the treatment of chronic hepatitis B viral infection.
    Dunkoksung W; Udomnilobol U; Ruengsatra T; Chauypen N; Prueksaritanont T
    Eur J Pharm Sci; 2024 Sep; 200():106834. PubMed ID: 38906232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379.
    Berke JM; Dehertogh P; Vergauwen K; Mostmans W; Vandyck K; Raboisson P; Pauwels F
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
    Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a New Sulfonamide Hepatitis B Capsid Assembly Modulator.
    Na HG; Imran A; Kim K; Han HS; Lee YJ; Kim MJ; Yun CS; Jung YS; Lee JY; Han SB
    ACS Med Chem Lett; 2020 Feb; 11(2):166-171. PubMed ID: 32071684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 4-oxotetrahydropyrimidine-1(2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virus.
    Hwang N; Ban H; Chen J; Ma J; Liu H; Lam P; Kulp J; Menne S; Chang J; Guo JT; Du Y
    Med Chem Res; 2021; 30(2):459-472. PubMed ID: 33456291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
    Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors.
    Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H
    Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biophysics-Guided Lead Discovery of HBV Capsid Assembly Modifiers.
    Fan Z; Pavlova A; Jenkins MC; Bassit L; Salman M; Lynch DL; Patel D; Korablyov M; Finn MG; Schinazi RF; Gumbart JC
    ACS Infect Dis; 2024 Apr; 10(4):1162-1173. PubMed ID: 38564659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.